secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001683168-25-009103
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma shareholders elect all five directors and approve equity plan increase at annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected: Dr. Slilaty, Sebaaly, Kiderchah, Natan, Keller received over 130M votes for.
- Ratification of M&K CPAS as independent auditor for 2025 approved with 132M for, 178K against.
- Amendment to 2023 Equity Incentive Plan to increase authorized shares to 683,000 approved with 130M for, 294K against.
- Broker non-votes: 1.77M on director elections and equity plan; 0 on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316825009103/0001683168-25-009103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316825009103/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-009103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer